TY - JOUR
T1 - Sentinel Lymph Node Biopsy in Pelvic Tumors
T2 - Clinical Indications and Protocols Under Investigation
AU - Maccauro, Marco
AU - Lorenzoni, Alice
AU - Crippa, Flavio
AU - Manca, Gianpiero
AU - Chondrogiannis, Sotirios
AU - Giammarile, Francesco
AU - Colletti, Patrick M.
AU - Cook, Gary J.
AU - Rubello, Domenico
PY - 2016/2/24
Y1 - 2016/2/24
N2 - ABSTRACT: Sentinel lymph node (SLN) sampling is an attractive alternative to complete lymphadenectomy. Based on the identification and sampling of the first LN draining a primary tumor, SLN biopsy is the most accurate and the only reliable method for microscopic nodal staging for solid tumors including breast cancer and melanoma. Lymph node status in pelvic tumors remains the most important prognostic factor for recurrence and survival and a major decision criterion for adjuvant therapy. We review the clinical indications, controversies, and perspective of SLN biopsy in male and female pelvic cancers.
AB - ABSTRACT: Sentinel lymph node (SLN) sampling is an attractive alternative to complete lymphadenectomy. Based on the identification and sampling of the first LN draining a primary tumor, SLN biopsy is the most accurate and the only reliable method for microscopic nodal staging for solid tumors including breast cancer and melanoma. Lymph node status in pelvic tumors remains the most important prognostic factor for recurrence and survival and a major decision criterion for adjuvant therapy. We review the clinical indications, controversies, and perspective of SLN biopsy in male and female pelvic cancers.
UR - http://www.scopus.com/inward/record.url?scp=84959098675&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959098675&partnerID=8YFLogxK
U2 - 10.1097/RLU.0000000000001184
DO - 10.1097/RLU.0000000000001184
M3 - Article
AN - SCOPUS:84959098675
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
SN - 0363-9762
ER -